Modification of vascular tone using iNOS under the control of a radiation-inducible promoter

被引:48
作者
Worthington, J [1 ]
Robson, T [1 ]
Murray, M [1 ]
O'Rourke, M [1 ]
Keilty, G [1 ]
Hirst, DG [1 ]
机构
[1] Univ Ulster, Sch Biomed Sci, Radiat Sci Res Grp, Newtownabbey BT37 0QB, Antrim, North Ireland
关键词
gene therapy; tumour vasculature; radiation; promoter; iNOS;
D O I
10.1038/sj.gt.3301224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It may be therapeutically advantageous to alter tumour blood supply specifically. Nitric oxide is a potent vasodilator which is produced in many tissues by the enzyme nitric oxide synthase (NOS). We have transfected cDNA for the inducible isoform of this enzyme (iNOS), under the control of the radiation-inducible promoter WAF1. The activity of the promoter was initially assessed using green fluorescent protein (GFP) in both endothelial cells and rat tail artery segments, Induction of protein expression by 9.5- and 4.5-fold respectively, was observed after a radiation dose of 4 Gy. Artery sections were then transfected with the WAF1/iNOS construct; this gave five-fold induction of iNOS protein after a dose of 4 Gy. The transfected artery was also tested functionally for relaxation, indicative of NO production. One hour after exposure to 4 Gy there was a significant (65%) relaxation of artery segments that had been preconstricted with phenylephrine. This could be partially reversed by the NOS inhibitor nitro-L-arginine. This study demonstrates that we can regulate vascular tone using an X-ray inducible promoter.
引用
收藏
页码:1126 / 1131
页数:6
相关论文
共 31 条
[1]  
ANDES EW, 1992, J INVEST DERMATOL, V99, P683
[2]   Adenovirus-mediated regulable target gene expression in vivo [J].
Burcin, MM ;
Schiedner, G ;
Kochanek, S ;
Tsai, SY ;
O'Malley, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :355-360
[3]   VASCULAR ATTACK AS A THERAPEUTIC STRATEGY FOR CANCER [J].
DENEKAMP, J .
CANCER AND METASTASIS REVIEWS, 1990, 9 (03) :267-282
[4]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[5]  
FUJISAWA H, 1995, J NEUROCHEM, V64, P85
[6]   Molecular biology of nitric oxide synthases [J].
Geller, DA ;
Billiar, TR .
CANCER AND METASTASIS REVIEWS, 1998, 17 (01) :7-23
[7]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[8]  
GOUD C, 1999, GEN PHARMACOL, V1, P51
[9]   SPATIAL AND TEMPORAL CONTROL OF GENE-THERAPY USING IONIZING-RADIATION [J].
HALLAHAN, DE ;
MAUCERI, HJ ;
SEUNG, LP ;
DUNPHY, EJ ;
WAYNE, JD ;
HANNA, NN ;
TOLEDANO, A ;
HELLMAN, S ;
KUFE, DW ;
WEICHSELBAUM, RR .
NATURE MEDICINE, 1995, 1 (08) :786-791
[10]  
HIRST DG, 1994, ADV EXP MOD BIOL, V345, P411